Knowledge About Covid-19 Infection in Pregnant Women

July 18, 2020 updated by: Mahmoud Alalfy, Aljazeera Hospital
Covid 19 is a pandemic infection developed in late 2019

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

It developed in China Then spread worl wide

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Giza, Egypt
        • Recruiting
        • Aljazeera( Al Gazeera) hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 42 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

Pregnant women at any GA

Description

Inclusion Criteria:

  • pregnant women

Exclusion Criteria:

  • non pregnant women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
pregnant women with abnormal labs
Mothers who have abnormal labs during pregnancy with abnormal coagulation profile
Other: labs
A group of questions to women regarding Corona with laboratory finding suggestive of covid 19 and coagulopathy
Other Names:
  • Questions and counseling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The number of pregnant women who have knowledge about covid-19
Time Frame: one month
The proper knowledge about covid-19
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Aljazeera Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2020

Primary Completion (Anticipated)

August 15, 2020

Study Completion (Anticipated)

August 20, 2020

Study Registration Dates

First Submitted

June 7, 2020

First Submitted That Met QC Criteria

June 7, 2020

First Posted (Actual)

June 9, 2020

Study Record Updates

Last Update Posted (Actual)

July 21, 2020

Last Update Submitted That Met QC Criteria

July 18, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Knowledge about covid 19

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Viral Infection

Clinical Trials on labs

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe